Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04408105 · ClinicalTrials.gov registry record
Survey Study on Barrett's Esophagus Screening
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 725
- Enrollment target
NCT04408105: Completed study, sponsored by University of Colorado, Denver.
NCT04408105 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 725 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04408105 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 725 participants
- Enrollment target
Study Summary
The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal Adenocarcinoma (EAC).
Primary Outcome
This investigator will conduct a survey study among primary care providers and gastroenterologists at 7 large health systems in the U.S.-including 4 tertiary care referral centers and 3 safety-net health systems. Based on constructs from Social Cognitive Theory and Theory of Reasoned Action, the survey will assess provider knowledge, attitudes, and barriers to BE screening among at-risk individuals.
Interventions
- BEHAVIORAL Patient Survey
- BEHAVIORAL Primary Care Provider Survey
- BEHAVIORAL Gastroenterologist Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 725 participants |
| Start Date | 2020-02-19 |
| Est. Completion | 2025-10-01 |
What the finished NCT04408105 record still lists
NCT04408105 is an observational study that tracks outcomes without assigning an intervention. The registered 725 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 3 interventions - of which Patient Survey is the first listed.
NCT04408105 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04408105 about?
NCT04408105 is a clinical study titled "Survey Study on Barrett's Esophagus Screening". The goal of this study is to optimize Barrett's Esophagus (BE) screening to reduce the incidence, morbidity, and mortality of Esophageal Adenocarcinoma (EAC).
What is the current status of trial NCT04408105?
This trial is currently completed. The enrollment target is 725 participants. The study started on 2020-02-19. Estimated completion is 2025-10-01.
What interventions are being tested in trial NCT04408105?
The interventions under investigation include: Patient Survey (BEHAVIORAL), Primary Care Provider Survey (BEHAVIORAL), Gastroenterologist Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT04408105?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05634967 · 725 participants
Kesimpta (Ofatumumab) Pregnancy Registry
- NCT06731478 · 726 participants · Phase 3
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- NCT06664619 · 724 participants · Phase 3
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma
- NCT06641466 · 723 participants · Phase 3
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI